DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,933,550 | +0.4% | 7,792 | -2.9% | 0.12% | +2.7% |
| Q2 2023 | $1,925,466 | -4.2% | 8,022 | +0.6% | 0.11% | -11.0% |
| Q1 2023 | $2,010,277 | -0.9% | 7,976 | +4.4% | 0.13% | -13.6% |
| Q4 2022 | $2,028,182 | +11.3% | 7,641 | +8.3% | 0.15% | -0.7% |
| Q3 2022 | $1,823,000 | -99.9% | 7,058 | +1.9% | 0.15% | +10.4% |
| Q2 2022 | $1,756,679,000 | +87646.2% | 6,929 | +1.5% | 0.13% | +0.8% |
| Q1 2022 | $2,002,000 | -8.5% | 6,826 | +2.7% | 0.13% | -6.3% |
| Q4 2021 | $2,188,000 | +18.7% | 6,646 | +8.3% | 0.14% | +8.4% |
| Q3 2021 | $1,844,000 | +12.2% | 6,137 | +0.2% | 0.13% | -0.8% |
| Q2 2021 | $1,643,000 | +23.0% | 6,126 | +3.2% | 0.13% | +17.9% |
| Q1 2021 | $1,336,000 | +31.4% | 5,937 | +29.6% | 0.11% | 0.0% |
| Q4 2020 | $1,017,000 | +126.5% | 4,580 | +119.5% | 0.11% | +2.8% |
| Q3 2020 | $449,000 | +21.7% | 2,087 | 0.0% | 0.11% | +1.9% |
| Q2 2020 | $369,000 | +28.1% | 2,087 | 0.0% | 0.11% | -1.8% |
| Q1 2020 | $288,000 | -14.5% | 2,087 | -5.1% | 0.11% | +6.9% |
| Q4 2019 | $337,000 | – | 2,198 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |